Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Deciding between cash back and rewards cards depends on your spending habits. Analyze your needs to find the best option for you.
26,062 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
July 2026 offers a compelling setup for patient investors. Here’s my top-ranked stock for July, why it stands out, an...
River Road Asset Management just added a notable new position in AptarGroup, acquiring 917,670 shares valued at about...
Three meme-rooted retail names are in focus as markets wobble: Kohl's, Chewy, and Wayfair are drawing fresh bets from...
Adobe is a powerhouse of creativity and marketing tech, but its stock has faced AI-driven noise. This guide breaks do...
Oracle stock sinks to a fresh 52-week low as a rating downgrade raises capital-structure questions while AI ambitions...
Investors are weighing bets on critical metals as supply chains shift and demand from EVs and renewables climbs. This...
A fresh review finds that a $10,000 investment in rsp’s equal-weight trap: $10,000 lagged a cap-weighted S&P 500 fund...
With $100, you can start building a resilient energy stock portfolio. This guide breaks down the smartest energy stoc...
A fresh look at SCHD shows that funding a cash-flow retirement with quarterly dividends still requires several millio...
New York City is turning a neighborhood challenge into a funding opportunity. This guide explains how ADU grants and ...
As Zillow prepares for 2026 earnings season, investors crave clarity on growth, margins, and how the housing cycle co...